Sepsis in Latent Autoimmune Diabetes in Adults with Diabetic Ketoacidosis: A Case Report by Rahmadi, Afdol et al.
 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2019 Oct 30; 7(20):3501-3504.                                                                                                                                                 3501 
 
ID Design Press, Skopje, Republic of Macedonia 
Open Access Macedonian Journal of Medical Sciences. 2019 Oct 30; 7(20):3501-3504. 
https://doi.org/10.3889/oamjms.2019.687 
eISSN: 1857-9655 
Tropical and Infectious Diseases Control and Management 
 
 
  
 
Sepsis in Latent Autoimmune Diabetes in Adults with Diabetic 
Ketoacidosis: A Case Report 
 
 
Afdol Rahmadi
*
, Eva Decroli, Alexander Kam 
 
Department of Internal Medicine, Faculty of Medicine, Andalas University, M. Djamil General Hospital, Padang, Sumatera 
Barat, Indonesia 
 
Citation: Rahmad A, Decroli E, Kam A. Sepsis in Latent 
Autoimmune Diabetes in Adults with Diabetic 
Ketoacidosis: A Case Report. Open Access Maced J Med 
Sci. 2019 Oct 30; 7(20):3501-3504. 
https://doi.org/10.3889/oamjms.2019.687 
Keywords: Latent Autoimmune Diabetes in Adult; 
Ketoacidosis Diabeticum; Septic 
*Correspondence: Afdol Rahmad. Department of Internal 
Medicine, Faculty of Medicine, Andalas University- M. 
Djamil General Hospital, Padang, Sumatera Barat, 
Indonesia. E-mail: afdolrahmadi@gmail.com 
Received: 14-Aug-2019; Revised: 15-Sep-2019; 
Accepted: 16-Sep-2019; Online first: 14-Oct-2019 
Copyright: © 2019 Afdol Rahmad, Eva Decroli, 
Alexander Kam. This is an open-access article distributed 
under the terms of the Creative Commons Attribution-
NonCommercial 4.0 International License (CC BY-NC 4.0) 
Funding: This research did not receive any financial 
support 
Competing Interests: The authors have declared that no 
competing interests exist 
Abbreviations: ANOVA: Analysis of variance; BRS: brain 
relaxation scale; CVP: central venous pressure; MAP: 
mean arterial pressure; GDT: goal-directed fluid therapy; 
PPV: pulse pressure variation; SPSS: Statistical package 
for social science; 
 
 
 
 
Abstract 
BACKGROUND: This case report intends to highlight the challenge in diagnosing type 1 diabetes on an adult 
patient. Latent Autoimmune Diabetes in Adult (LADA) types I diabetes Mellitus, which found in adulthood and 
characterised by progressive damage to pancreatic β cells that happened slowly. Incidence of LADA is around 2-
12% of the total diabetes population. Sepsis in LADA patients will trigger diabetic ketoacidosis (DKA).  
CASE REPORT: We report a case of a 33-year-old woman patient presents with decreased consciousness 
accompanied by rapid and deep breathlessness for 1 day. Before, the patient complains of fever and cough. 
Physical examination found soporous, blood pressure 120/80 mmHg, pulse 110 x/minute, temperature 38.8°C, 
breathing 32 x/minute Kussmaul. Bronchovesicular breath crackles in both lower lung fields. leukocytes were 
22,100/mm
3
, random blood glucose 638 mg/dL, urine ketone +++, HbA1C 17.2%, HOMA IR less than 2 units. C-
peptide 0.3 ng/mL and GADAs 16.9 U/mL. Chest Xray indicated bronchopneumonia. Patients were diagnosed 
with diabetic ketoacidosis, LADA, and sepsis caused by bronchopneumonia. Patient treated with DKA 
management and sepsis. On the second day, the treatment of DKA was resolved and continued with the 
administration of short-acting insulin and regular long-acting.  
CONCLUSION: Sepsis in LADA with DKA requires fast and appropriate management. Further search is needed 
to diagnose LADA. 
 
 
 
 
 
 
 
Introduction 
 
Latent Autoimmune Diabetes in Adult (LADA) 
types I diabetes mellitus found in adulthood which is 
characterised by progressive damage to β cells that 
lasts slowly [1]. Indonesia population was about 237.6 
people in 2010, and make it become the world’s fourth 
most populated country. Indonesia has the seventh-
largest number of diabetic patients (7.6 million) [2], [3]. 
LADA occurs in about 2 - 12% among diabetic 
patients in the entire diabetes population. Symptoms 
of LADA are similar to Type 1 diabetes but are found 
in adulthood. The slow progression of pancreatic β 
cell damage in LADA is initially almost always 
diagnosed as type 2 diabetes mellitus [4], [5].
 
The Diagnosis of LADA is made from the 
clinical complaints of diabetes symptoms 
accompanied by high fasting plasma glucose, low C-
peptide, without insulin resistance characterised by 
low HOMA IR [6]. Due to the slow progression of 
pancreatic β cell damage usually, in the first 6 months, 
LADA patients still respond with oral anti-diabetic 
therapy, but when plasma glucose levels can no 
longer be overcome with oral anti-diabetes drugs and 
lifestyle changes, daily insulin injections are needed 
[7]. 
It is estimated that more than 50% of patients 
diagnosed with type 2 diabetes without obesity are 
LADA, but not all LADA patients are underweight; 
some are overweight [6]. Glutamic Acid 
decarboxylase autoantibody (GADA), islet cell 
autoantibody (ICA), insulinoma-associated (IA-2) and 
zinc transporter autoantibodies (ZnT8) were found in 
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patients with LADA type DM [6], [7]. LADA patients 
usually have low C-peptide levels, although 
sometimes in moderate amounts according to the 
progression of the disease. While patients with insulin 
resistant or type 2 diabetes mellitus, usually have high 
C-peptide levels [8], [9]. 
 
 
Case Report 
 
A 33-year-old woman comes with a major 
complaint is suddenly unconsciousness accompanied 
by shortness of breath that is fast and deep for 1 day. 
Before declining consciousness, the patient complains 
of fever, cough, and vomiting.  
 
Figure 1: Chest Xray 
 
On physical examination found soporous awareness, 
blood pressure 120/80 mmHg, pulse 110 x/minute, 
temperature 38.8°C, breathing 32 x/minute Kussmaul, 
BMI: 16.8 kg/m2. Bronchovesicular breath, fine wet 
cracks in both lower lung fields. On laboratory 
examination, leukocytes were obtained 22,100/mm3, 
blood sugar levels when 638 mg/dL, urine ketone +++, 
HbA1C 17.2%, HOMA IR was less than 2 units. C-
peptide 0.3 ng/mL and GADAs 16.8 U/mL. Chest Xray 
indicated bronchopneumonia and plain radiograph of 
the pancreas, and no pancreatic calcification was 
found (Figure 1 and Figure 2). 
Patients were diagnosed with diabetic 
ketoacidosis, LADA, and sepsis caused by 
bronchopneumonia. The management of DKA in 
these patients is given fluid resuscitation, intensive 
plasma glucose control with DKA, intravenous insulin 
protocol, and trigger factor control, namely infection 
with broad-spectrum cephalosporin class 3 antibiotics. 
On the second day, the DKA treatment is resolved, 
and insulin therapy is given for hyperglycemia. Short-
acting and long-acting regularly. 
 
Figure 2: Pancreatic Xray 
 
 
 
Discussion  
 
Infections are still the main cause of morbidity 
and mortality in diabetics patient. Diabetes could 
increase the risk of developing infections and sepsis 
to the patient [10]. The main reason for diabetes 
predisposes to infection appears to host response 
abnormalities, particularly in neutrophil chemotaxis, 
adhesion and intracellular killing, defects that have 
been attributed to the effect of hyperglycaemia [11]. 
There is also evidence for defects in humoral 
immunity, and this may play a larger role than 
previously. Diabetes is associated with elevations in 
C-reactive protein (CRP), tumour necrosis factor-
alpha (TNF-α), interleukin (IL)-6 and IL-8, but no 
differences are seen in circulating cell surface 
markers or coagulation markers between patients with 
and without diabetes in the context of sepsis [11], [12]. 
Organ systems where bacterial infections 
predominate as well as fungal diseases were 
associated with substantial increases in magnitude 
among patients with both T1DM and T2DM, but risks 
were consistently higher for T1DM. Patients with 
T1DM are at approximately double the risk of patients 
with T2DM for infection-related to death. Bacterial 
eradication is needed to treat the infection. Antibiotic 
regiments are not different in a patient with or without 
diabetes [11]. 
Lung infections suffered by these patients 
trigger sepsis which then increases the risk of diabetic 
ketoacidosis. In stress situations, the body is thought 
to activate the central nervous system and 
neuroendocrine axes which release hormones such 
as catecholamines, glucagon and cortisol which are 
known to stimulate hepatic glucose production and 
lead to hyperglycemia [13], [14].  
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Ketoacidosis is a metabolic state associated 
with pathologically high serum and urine 
concentrations of ketone bodies, namely acetone, 
acetoacetate and beta-hydroxybutyrate. DKA can 
occur in patients with diabetes mellitus. This may be 
caused by precipitating physiologic stress or in some 
cases, maybe the initial clinical presentation in 
patients with previously undiagnosed diabetes [14], 
[15]. Some of the more common risk factors that can 
precipitate the development of extreme hyperglycemia 
and subsequent ketoacidosis are infection, non-
adherence to insulin therapy, acute major illnesses 
like myocardial infarction, sepsis, pancreatitis, stress, 
trauma, and the use of certain medications DKA 
management must be carried out quickly and 
precisely given the high mortality rate [16].  
DKA management protocols are replacement 
of lost fluids and salts, administration of insulin and 
management of infection. Considering that severe 
acidosis can interfere with the balance of 
homeostasis, it is reasonable to treat patients with pH 
< 7.0 using sodium bicarbonate. DKA in these patients 
can be resolved well because of the provision of 
therapy following the protocol, which are fluid 
resuscitation, blood sugar control and infection 
management with the administration of broad-
spectrum antibiotics, which is the third generation of 
cephalosporin [11], [17]. 
A 33-year-old woman with a diagnosis of 
diabetic ketoacidosis, LADA, and sepsis caused by 
bronchopneumonia was treated. The problem with this 
patient is whether this patient is type 2 DM or another 
type of DM, given that clinically type 2 DM and other 
types of DM can be found in young adults [3], [4]. 
According to the literature where the 
percentage is 10%-20%. Usually, 85% are overweight 
or obese; urinary ketones are found in 33% of cases 
while 5%-25% with ketoacidosis [17]. DKA triggers in 
these patients are septic bronchopneumonia 
(Masharani, 2010). This is consistent with the 
literature that the most common trigger factor of DKA 
is an infection, and is thought to trigger more than 
50% of DKA cases [15]. In infection, there will be an 
increase in cortisol and glucagon secretion so that 
there is a significant increase in blood sugar levels 
[12]. 
At the beginning of admission, this patient is 
diagnosed with type 2 DM, so to ensure diagnostic 
tests are carried out several tests including HOMA IR, 
C-peptide and GADAs. In these patients, there was a 
low HOMA IR; this was not my type 2 DM. Then 
examination was performed C-Peptide to prove 
whether this patient was pure type 1 DM or another 
type of DM. In these patients, C-Peptide is low, which 
is 0.3 ng/mL. The results of the examination C-peptide 
describe endogenous insulin secretion. Insulin and C-
peptide are secreted equimolarly and released into 
the circulation through the portal vein. Low C-peptide 
indicates that endogenous insulin production in these 
patients is low and that high levels of GADAs are 
obtained, which is 16.9 U/mL, which indicates these 
patients have clear antibodies. In low HOMA IR 
conditions, low C-peptide and autoantibody 
abnormalities indicate that this patient does not type 2 
DM but LADA type DM [18], [19], [20]. 
Diabetes is a much heterogeneous disease 
than the present subdivision into type 1, and 2 
assumes. Both type 1 and type 2 diabetes seem to 
result from a collision between genes and 
environment [18]. Type 1 diabetes is believed to be an 
autoimmune disease characterised by genetic, 
immunological and metabolic features. The incidence 
is highest in children, but adults also get the disease. 
Data reported in LADA show that this is the most 
frequent form of adult-onset autoimmune diabetes and 
may account for 2% to 12% of all cases of diabetes in 
the adult population. Moreover, multicenter studies 
carried out in Europe, Asia and North America, 
reported that 4% to 14% of patients diagnosed with 
T2DM are positive for T1DM associated 
autoantibodies which are diagnostic for LADA [17]. In 
LADA, metabolic changes at diagnosis reflect a broad 
phenotype ranging from diabetic ketoacidosis to mild 
non-insulin-requiring diabetes [20]. 
Adult-onset autoimmune diabetes and 
childhood-onset type 1 diabetes are barely 
distinguishable immunologically. In LADA, the 
dominant autoantibody is GADA and lower C-peptide 
levels. At diagnosis, the clinical phenotype in patients 
with autoimmune diabetes is remarkably broad, 
ranging from diabetic ketoacidosis to diabetes that 
can be controlled with diet alone. Patient with LADA 
tend to have a lower age at diabetes onset, lower BMI 
and waist-to-hip ratio, but a more pronounced loss of 
C-peptide and an increased likelihood of insulin 
treatment [9]. 
To diagnose LADA, the Immunology of 
Diabetes Society has established three main criteria 
including (1) adult age of onset (> 30 years); (2) 
presence of any islet cell autoantibody; and (3) 
absence of insulin requirement for at least 6 months 
after diagnosis. However, the definition of LADA 
remains controversial, and open debate regarding 
these diagnostic criteria still exist [8]. 
A correct therapeutic strategy for LADA 
patients should aim to the preservation of residual β-
cell function as well as improvement of 
neurometabolic control, to reduce the risk of long-term 
complications. Maintenance of β-cell function, as 
demonstrated by the Diabetes Control and 
Complication Trial, is indeed associated with a 
reduction of long teen diabetic complications [6]. 
In conclusion, sepsis in LADA with DKA 
requires fast and appropriate management. Further 
search is needed to diagnose LADA. LADA type DM 
is initially almost always diagnosed with type 2 DM or 
other types of DM because pancreatic β cell damage 
occurs progressively slowly (ADA, 2004). Diagnosis of 
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LADA patients are found clinically in diabetes, 
increased plasma glucose, HOMA IR less than 2 
units, low C-peptide and the presence of 
autoantibodies. 
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